Savina Malancona
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tandem mass spectrometry-based assay for heparan-N-sulphatase in paediatric CSF: A potential pharmacodynamic biomarker for mucopolysaccharidosis type IIIA therapy.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: July 29, 2024
Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration.
Journal: Journal of medicinal chemistry
Published: December 15, 2020
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein.
Journal: ACS medicinal chemistry letters
Published: December 16, 2019
Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides.
Journal: ACS medicinal chemistry letters
Published: October 31, 2018
Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein.
Journal: ACS medicinal chemistry letters
Published: October 26, 2018
Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
Journal: Bioorganic & medicinal chemistry letters
Published: September 25, 2018
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
Journal: ACS chemical biology
Published: December 14, 2017
Discovery of a Selective Series of Inhibitors of Plasmodium falciparum HDACs.
Journal: ACS medicinal chemistry letters
Published: December 07, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026